Management of dupilumab-associated ocular surface diseases in atopic dermatitis patients
Published inSwiss medical weekly, vol. 151, w30020
Publication date2021-08-20
First online date2021-08-20
Abstract
Keywords
- Antibodies, Monoclonal, Humanized
- Asthma
- Conjunctivitis / chemically induced
- Conjunctivitis / drug therapy
- Dermatitis, Atopic / drug therapy
- Humans
- Severity of Illness Index
- Treatment Outcome
Affiliation
Research group
Citation (ISO format)
GUEX-CROSIER, Yan et al. Management of dupilumab-associated ocular surface diseases in atopic dermatitis patients. In: Swiss medical weekly, 2021, vol. 151, p. w30020. doi: 10.4414/SMW.2021.w30020
Main files (1)
Article (Published version)
Identifiers
- PID : unige:159815
- DOI : 10.4414/SMW.2021.w30020
- PMID : 34495603
Commercial URLhttps://smw.ch/article/doi/SMW.2021.w30020
ISSN of the journal0036-7672